Skip to main content
. Author manuscript; available in PMC: 2015 May 11.
Published in final edited form as: Gynecol Oncol. 2011 Jan 26;121(2):273–279. doi: 10.1016/j.ygyno.2010.12.362

Table 3.

Serum volociximab concentrations (µg/mL) in treatment cycle 1 (PK population N = 16).

Day Infusion Day 1 Infusion Day 15 Infusion Day 29 Infusion Day 50
Post-dose Pre Post Pre Post Pre Post
N 16 13 13 10 10 8 8
Mean ± SD (range) 402 ± 84 (233–572) 279 ± 88 (101–398) 680 ± 215 (209–950) 477 ± 183 (157–677) 856 ± 238 (390–1060) 762 ± 173 (443–1020) 1203 ± 205 (813–1430)